Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group

Title
Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 31, Issue 2, Pages 246-256
Publisher
Elsevier BV
Online
2020-01-06
DOI
10.1016/j.annonc.2019.12.006

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now